The chromosomal rearrangement of anaplastic lymphoma kinase (ALK) was first described in 2007 in anaplastic large cell lymphomas, and Soda et al. reported that it occurs in ~7% of patients with NSCLC [68]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.